While initially approved for type 2 diabetes management, this medication has shown clinically relevant weight reduction benefits in individuals without diabetes
Bruls YM, de Ligt M, Lindeboom L, Phielix E, Havekes B, Schaart G, Kornips E, Wildberger JE, Hesselink MK, Muoio D, Schrauwen P, Schrauwen-Hinderling VB (2020) Mitochondrial dysfunction: a potential therapeutic target to treat Alzheimers Disease
If any of those apply, talk to a qualified clinician before considering 5-Amino-1MQ for any reason
Upon release, Nrf2 translocates to the nucleus where it can bind to the antioxidant response element (ARE) located in the promoter region of genes coding for antioxidant enzymes and scavengers